Enlivex Therapeutics (ENLV) Investor Presentation - Slideshow

| --- | --- | |-------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------| | The problem: | The primary reason: | | Too many patients with life- threatening diseases do not respond to existing therapies | The most prevalent life- threatening diseases involve multiple pathways of the immune system, making them highly evasive | Sepsis is the 3rd leading ...